Sanofi and Regeneron’s Dupixent approved as the first targeted medicine in the EU in over a decade for chronic spontaneous…
Skills gap widespread; gender gap narrowing; youth proficiency low ZURICH, Nov. 19, 2025 /PRNewswire/ -- EF (Education First), a global…
KOLKATA, India, Sept. 25, 2025 /PRNewswire/ -- In a major milestone for cancer care in Eastern India, doctors at Apollo…